Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTFL
2951
Heartflow Inc
HTFL
$4.28B
| $728K | ﹤0.01% |
24,811
+11,831
| +91% | +$355K |
|
2952
ADMA Biologics
ADMA
$2.1B
| $727K | ﹤0.01% |
86,894
-56,968
| -40% | -$519K |
|
2953
Unitil
UTL
$930M
| $727K | ﹤0.01% |
13,799
+649
| +5% | +$33.7K |
|
2954
Genco Shipping & Trading
GNK
$1.14B
| $726K | ﹤0.01% |
29,284
-61,344
| -68% | -$1.48M |
|
2955
Castle Biosciences
CSTL
$1.09B
| $723K | ﹤0.01% |
30,330
+3,520
| +13% | +$78.4K |
|
2956
The GEO Group
GEO
$4.11B
| $723K | ﹤0.01% |
24,468
-25,457
| -51% | -$577K |
|
|
TBPH
2957
DELISTED
Theravance Biopharma
TBPH
| $723K | ﹤0.01% |
42,525
-3,851
| -8% | -$63.8K |
|
2958
Manitowoc
MTW
$798M
| $722K | ﹤0.01% |
52,010
-1,743
| -3% | -$22.1K |
|
2959
First Bank
FRBA
$441M
| $722K | ﹤0.01% |
40,736
-3,606
| -8% | -$57.9K |
|
2960
CALL
Sable Offshore Corp
SOC
$744M
| $721K | ﹤0.01% |
+234,200
| New | +$2.98M |
|
2961
iShares Russell 2000 Value ETF
IWN
$14B
| $721K | ﹤0.01% |
3,258
-14,050
| -81% | -$2.94M |
|
2962
CRA International
CRAI
$1.02B
| $721K | ﹤0.01% |
5,064
-618
| -11% | -$92.9K |
|
2963
Krispy Kreme
DNUT
$501M
| $721K | ﹤0.01% |
204,114
+16,203
| +9% | +$57.8K |
|
2964
PUT
Sarepta Therapeutics
SRPT
$1.97B
| $719K | ﹤0.01% |
40,000
| – | – |
|
2965
Personalis
PSNL
$1.76B
| $716K | ﹤0.01% |
53,437
+1,860
| +4% | +$15.1K |
|
2966
Pharvaris
PHVS
$2.25B
| $716K | ﹤0.01% |
20,702
+16,334
| +374% | +$494K |
|
2967
Harrow
HROW
$1.24B
| $714K | ﹤0.01% |
16,803
+5,200
| +45% | +$193K |
|
2968
Triumph Financial Inc
TFIN
$1.47B
| $712K | ﹤0.01% |
9,335
-79,468
| -89% | -$5.41M |
|
2969
CALL
Absci
ABSI
$1.67B
| $712K | ﹤0.01% |
+61,400
| New | +$346K |
|
2970
BancFirst
BANF
$3.65B
| $711K | ﹤0.01% |
6,396
-4,231
| -40% | -$474K |
|
2971
Viemed Healthcare
VMD
$339M
| $710K | ﹤0.01% |
62,287
-9,990
| -14% | -$98.9K |
|
2972
Atmus Filtration Technologies
ATMU
$3.65B
| $709K | ﹤0.01% |
13,904
-294,821
| -95% | -$16M |
|
|
MAZE
2973
Maze Therapeutics
MAZE
$1.45B
| $708K | ﹤0.01% |
23,733
+14,471
| +156% | +$379K |
|
2974
Perrigo
PRGO
$2.14B
| $705K | ﹤0.01% |
67,834
+56,628
| +505% | +$623K |
|
2975
PUT
State Street SPDR S&P Retail ETF
XRT
$338M
| $702K | ﹤0.01% |
8,000
| – | – |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.